As we look for new emerging growth opportunities in the explosive small-cap biotech space, Patient Access Solutions, Inc. (OTCMKTS:PASO) has popped up the radar of late given the interesting number of factors that seem to be coalescing for this speculative name in the rapidly growing Autism space.
The company recently announced an update to its shareholders focusing on its activities. The main focus of the release was on corporate reporting, leadership, new responsibilities at the top of the medical staff, and M&A. Specifically, the company has initiated the process to update and complete its audited financial reporting requirements. The estimate is to have the process completed within 45-60 days. That’s a big factor and should contribute to a sense of increased transparency and credibility. However, we also saw a note about the possibility of an upcoming acquisition of a revenue-producing property, which could propel action in a big way very quickly.
Patient Access Solutions Inc. (OTCMKTS:PASO) was incorporated in 2006 as an innovative technology solution geared toward the healthcare sector.
According to a detailed business plan from the company, PASO has predicated its big-picture strategy on a foundation built of the fundamental recognition that healthcare is the largest industry in the world and that it offers many opportunities to capture data and complete transactions electronically, the company began to apply its technology knowledge in this marketplace. Patient Access Solutions, Inc., as a technology solutions provider is focused on quality and service within the healthcare community, with an overall focus of using innovative and secure technology to facilitate their client’s needs.
Perhaps most interestingly, the company has opened the C.I.I.T. Medical Center (Center for Integrative and Innovative Therapies) which specializes in chronic health conditions including Autism, Concussion, PTSD and numerous other brain related, and biomedical conditions including Depression, Anxiety, Thyroid conditions and much more. The Center will offer innovative healthcare strategies for children and adults and additionally implement novel and effective strategies of rehabilitation for post-concussion syndrome and like syndromes. Additionally, the Center will be operated with an eye to leverage each patient to include all their family members for every non-invasive, non-radiation test currently known.
Autism Spectrum Disorder (ASD) is the fastest growing developmental disability and is diagnosed more frequently than AIDS, cancer, and diabetes combined, with 1 in 59 children now being diagnosed (CDC, 2018). With an annual growth rate of 10 – 17 %, this represents a problem of epidemic proportions.
As of November 2012, new legislation took effect mandating insurance coverage for all children with an autism diagnosis up to $45,000/year/child in New York State, where the C.I.I.T. clinic is based. This Center is located in Plainview, New York in a 12,500 square foot facility. Now that this Center is completely up and operational, the company plans to build additional locations on a nationwide basis, encompassing all of the protocols.
In the Spotlight?
As noted above, PASO recently announced an update on what’s been going on at the company over recent weeks. And the scope of activity is impressive and may help to further establish this innovative biotech as a buzz play as we kick off the new year. The technical context for this announcement is a clear bid, with shares acting extremely well over the past five days, up about 48% in that timeframe. Shares of the stock have powered higher over the past month, rallying roughly 503% in that time on strong overall action. Interest is clearly burgeoning.
According to the release, the company is focused on engaging proven industry veterans to assist in executing its growth strategy and is pleased to announce a key addition to the management team: “Dr. Joelle Vital, MD – Chief Medical Officer: Dr. Vital will spear-head the integration of the center’s staff, concentrate on the recruitment of physician specialists, and oversee treatment protocols. Dr. Vital is a specialist in integrative internal medicine. She received her medical degree from Benemérita Universidad Autónoma de Puebla, MX, and completed her residency at Brooklyn Hospital Center in New York City. She has been in practice for more than 20 years.”
In addition, on the M&A front, the company has been in negotiations with multiple revenue producing healthcare practices. The company hopes to provide its shareholders with an update regarding those opportunities upon execution of those agreements.
Patient Access Solutions, Inc. (OTCMKTS:PASO) managed to rope in revenues totaling $196K in overall sales during the company’s most recently reported quarterly financial data.